Ocera Therapeutics Announces Appointment of Steven P. James to Board
September 18, 2014 at 16:06 PM EDT
Ocera Therapeutics, Inc. (Nasdaq: OCRX), a clinical stage biopharmaceutical company focused on acute and chronic orphan liver diseases, ...